Transmedics Group, Inc. current report, 17 December 2020

Full document

TransMedics Group, Inc. — Form 8-K Summary

Business Context and Reporting Period

TransMedics Group, Inc. filed a Current Report on Form 8-K dated December 17, 2020, reporting a board appointment and related director compensation arrangements. The report was signed and filed on December 23, 2020.

Financial Metrics and Liquidity

This filing does not provide revenue, earnings, cash flow, margins, debt, liquidity, or other operating financial metrics.

Material Changes

  • Merilee Raines was appointed to the Board of Directors and the Audit Committee, effective January 1, 2021.
  • Ms. Raines was appointed Chair of the Audit Committee, effective June 1, 2021.
  • She will receive an initial option to purchase 18,000 shares of common stock. One-third vests on the first anniversary of the grant date, with the remainder vesting in equal monthly installments over the following two years, subject to continued board service.
  • Annual cash compensation will be $40,000 for board service, plus $10,000 for Audit Committee service, increasing to $20,000 while serving as Audit Committee Chair. Payments are made quarterly in arrears and prorated for partial quarters.
  • Ms. Raines is eligible for future annual equity awards under the company’s non-employee director compensation policy and will enter into the company’s standard indemnification agreement.

Guidance, Outlook, Risks, and Unusual Items

The filing provides no financial guidance or management outlook. The primary disclosed item is the addition of an independent director and related equity and cash compensation obligations. The option award is subject to continued service, and the filing does not state the option exercise price or grant date.

Investor Verification Items

  • Confirm the final option grant date, exercise price, accounting valuation, and dilution impact.
  • Review subsequent filings for Ms. Raines’s continued service and Audit Committee leadership.
  • Assess the company’s broader director compensation policy and aggregate equity award obligations.
  • Consult the company’s periodic financial filings for operating performance, liquidity, debt, and outlook information not included in this Form 8-K.